StreetAlpha.app
Home › Stocks › PLSE

Pulse Biosciences, Inc. (PLSE)

Healthcare
$45.55
▲ +2.57%
LAST CLOSE · NOV 20

Pulse Biosciences develops nanosecond pulsed energy devices for tissue ablation, with a focus on treating heart rhythm conditions. It last closed at $45.55 on Nov 20, up 2.57% on the day. The next earnings report for PLSE is expected around Thu, Feb 18, 2027, after the close. For the quarter ended Sep 2026, PLSE reported EPS of -$0.32 on revenue of $395,000, with revenue up 359.3% from a year ago. Over its last 8 reports the stock moved an average of 6.4% the session after earnings. Over the last 12 months PLSE insiders bought $13.5M of stock on the open market and sold $2.9M, according to SEC Form 4 filings.

AI Auto Pilots
Is PLSE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PLSE.

Key Stats

Last 12 months
Results
Revenue
$1.5M
+1637.2% vs a year ago
Net income
−$83.7M
−5603.9% margin
EPS (diluted)
−$1.21
Free cash flow
−$63.7M
−4263.9% margin
Valuation
Market cap
$3.4B
73.5M shares
P/E
–
No P/E while losing money
Price to sales
2242.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$36.7M
At Sep 30
Shareholder equity
$183.6M
Shares outstanding
73.5M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.4M$1.4MFY2021FY2022: $700K$700KFY2022FY2023: $0$0FY2023FY2024: $0$0FY2024FY2025: $350K$350KFY2025

From PLSE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 18
Estimated date · After the close
Reported EPS
-$0.32
Quarter ended Sep 2026
Year ago EPS
-$0.29
Same quarter last year
Revenue
$395,000
+359.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.32Dec '24Mar 2025: -$0.25Mar '25Jun 2025: -$0.28Jun '25Sep 2025: -$0.29Sep '25Dec 2025: -$0.26Dec '25Mar 2026: -$0.27Mar '26Jun 2026: -$0.36Jun '26Sep 2026: -$0.32Sep '26Latest -$0.32
Revenue by quarter
Dec 2024: $0Dec '24Mar 2025: $0Mar '25Jun 2025: $0Jun '25Sep 2025: $86,000Sep '25Dec 2025: $264,000Dec '25Mar 2026: $401,000Mar '26Jun 2026: $434,000Jun '26Sep 2026: $395,000Sep '26Latest $395,000
How PLSE moved after its last 8 reports
Average move the session after a report ±6.4%
Nov 5, 2026After the close+0.4%
Aug 6, 2026After the close+10.9%
May 4, 2026Time not announced−3.8%
Feb 19, 2026After the close−14.6%
Nov 5, 2025After the close−3.3%
Aug 12, 2025After the close+11.2%
May 8, 2025After the close+1.3%
Mar 28, 2025Time not announced+6.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PLSEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PLSE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PLSE

Technical Analysis

PLSE · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 14% below its 20 day and 12% below its 50 day average. It is 25% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the 100 day average at $45.51, and the nearest resistance the swing high (Aug 7) at $45.90.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 8.6%/day
Key levels
$58.9452 week high+29.4%
$51.7920 day average+13.7%
$51.1550 day average+12.3%
$46.50Pivot R1+2.1%
$45.90Swing high (Aug 7)+0.8%
$45.55Last close
$45.51100 day average−0.1%
$45.11Pivot−1.0%
$44.16Pivot S1−3.1%
$43.32Swing low (Oct 16)−4.9%
$34.13200 day average−25.1%
$12.5652 week low−72.4%
Indicators
RSI (14)40.91Middle of its rangeNeutral
MACD-1.44Below its signal lineBearish
Stochastic13.4Near the bottom of its rangeOversold
ADX (14)22.1Weak trend
Williams %R-84.8Oversold below −80, overbought above −20Oversold
CCI (20)-144.3Oversold below −100, overbought above 100Oversold
Rate of change−14.5%Change over 10 sessionsBearish
ATR (14)$3.90Typical daily range, 8.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for PLSE

What happened before

See how PLSE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PLSE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PLSE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PLSEHow many large options trades hit PLSE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

PLSE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲94 buying vs 36 selling
  • ▲Held by funds +6.3 pts
  • ▲Funds holding +36
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding142106+34.0%
In funds' top 1000–
Held by funds20.9%14.6%+6.3 pts
New / increased43 / 5120 / 43+49.2%
Reduced / sold out27 / 921 / 10+16.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PLSE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PLSE Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$13.5M4 buys · 3 insiders
Sold$2.9M3 sales · 1 insider
100% of the selling was under pre-arranged trading plans.
Cluster buy: 2 insiders bought $13.3M between May 11 and May 11.
2026-02 sold $2.9M2026-05 bought $13.3M2026-08 bought $100K2026-09 bought $100KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 1Liane Rae TeplitskyCOOBuy2,025$49.37$100K
Aug 28Liane Rae TeplitskyCOOBuy2,070$48.29$100K
May 11Robert W DugganDirectorBuy660,233$19.69$13.0M
May 11Paul A LavioletteCEOBuy15,000$19.69$295K
Feb 18Kevin Patrick DanahyChief Commercial OfficerSale plan5,000$23.64$118K
Feb 17Kevin Patrick DanahyChief Commercial OfficerSale plan60,000$23.51$1.4M
Every insider buy and sale for PLSE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See PLSE insider trades →

From SEC Form 4 filings by PLSE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PLSE is in one of them and how their past PLSE trades turned out.

PLSE in the AI portfolios
Loading…

PLSE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PLSE in an article yet. Here's the latest on the wider market.

PLSE in the news

About Pulse Biosciences

Pulse Biosciences is a medical device company based in Hayward, California. It develops technology that delivers very short pulses of electrical energy to clear or kill targeted cells without heating the surrounding tissue. Its nPulse System and Vybrance Percutaneous Electrode are designed for surgeons and clinical sites performing soft tissue ablation. The company is also developing cardiac surgical and catheter devices for treating atrial fibrillation, a heart rhythm condition.

Headquarters
Hayward, CA